Rheumatoid arthritis drug shows promise against COVID-19, study finds
A drug against rheumatoid arthritis called baricitinib could potentially be repurposed to treat patients with COVID-19, according to a study
Read moreA drug against rheumatoid arthritis called baricitinib could potentially be repurposed to treat patients with COVID-19, according to a study
Read moreWalter and Eliza Hall Institute researchers have revealed new details about how joint inflammation evolves in rheumatoid arthritis, and the
Read more